Pembrolizumab for locally advanced cervical cancer

Lancet. 2024 Nov 23;404(10467):2049-2050. doi: 10.1016/S0140-6736(24)02229-3.

Authors

Naoya Murakami¹, Noriyuki Okonogi², Yasuhisa Terao², Naoto Shikama²

Affiliations

¹ Juntendo University, Tokyo 113-0033, Japan. Electronic address: n.murakami.zi@juntendo.ac.jp.
² Juntendo University, Tokyo 113-0033, Japan.

PMID: 39580197
DOI: 10.1016/S0140-6736(24)02229-3

No abstract available

Publication types

Letter